Nov 7, 2016 by Brian FeroldiSkyworks Solutions Inc.'s Revenue and Profit Fall, but Management Is OptimisticThe company reminded investors of all of the trends that are working in its favor.
Nov 5, 2016 by Brian Feroldi3 Best-Performing Stocks in OctoberGap, Netflix, and Akamai Technologies all posted huge monthly gains in October. Are any of them worthy buying after the recent run?
Nov 4, 2016 by Brian FeroldiNIC Inc. Turns on Its Dividend SpigotThe provider of digital government services continued its recent history of steady growth.
Nov 4, 2016 by Brian FeroldiIs This Why Shares of TherapeuticsMD Inc. Rose Today?Shareholders saw something that they liked in the company's third-quarter earnings report.
Nov 4, 2016 by Brian FeroldiWhy Cerus Corporation is Soaring TodayShareholders cheer the blood-transfusion specialist's third-quarter earnings report.
Nov 4, 2016 by Brian Feroldi, Jason Hall, and Steve SymingtonHow I'd Invest $500 TodayDo you have a few hundred dollars and want to find a good stock to buy? Our team of Fools thinks these three stocks are great choices.
Nov 3, 2016 by Brian FeroldiHere's Why PTC Therapeutics, Inc. Is Crashing TodayShares drop after the company projects that sales of Translarna could decline in the upcoming quarter.
Nov 3, 2016 by Brian FeroldiHorizon Global Corp.'s Revenue and Profits Fall, but Bullish Guidance Saves the DayRevenue and adjusted net income dropped in the third quarter, but shares rose after management issued an upbeat outlook.
Nov 3, 2016 by Brian FeroldiWhy Diplomat Pharmacy, Inc. Is Plunging TodayThe specialty pharmacy's shares tumbled after management reported weak quarterly results and lowered guidance.
Nov 3, 2016 by Brian Feroldi, Jason Hall, and Timothy Green3 Small-Cap Stocks to Buy in NovemberOur team of contributors thinks that these three small companies are poised for significant growth in the years ahead.
Nov 3, 2016 by Brian FeroldiHere's Why NxStage Medical, Inc.'s Stock Is Popping TodayShares jump in response to strong third-quarter earnings and a better-than-expected outlook from management.
Nov 2, 2016 by Brian Feroldi, Cory Renauer, and George Budwell, PhD3 Top Biotech Stocks to Buy in NovemberLooking for a biotech stock to buy this month? Our healthcare contributors believe that these three companies are compelling investments.
Nov 2, 2016 by Brian FeroldiHere's Why Insulet Corporation Is Plunging TodayShares of the insulin pump maker dropped in the wake of disappointing quarterly results from two other diabetes-focused companies.
Nov 2, 2016 by Brian FeroldiPaycom Software, Inc Posts Strong Revenue and Profit GrowthShares of the payroll and HR technology company declined Wednesday despite the company's reporting strong quarterly results and issuing a bullish outlook.
Nov 2, 2016 by Brian FeroldiHere's Why DexCom, Inc. Is Plunging TodayShares of the medical-device maker fell hard after it reported mixed quarterly results and issued disappointing guidance.
Nov 2, 2016 by Brian FeroldiIs This Why Paycom Software Inc. Is Dropping Today?Shares fall by double digits after the payroll technology provider reported strong quarterly results and issued bullish guidance. Is it simply a matter of the company's valuation getting ahead of itself?
Nov 1, 2016 by Brian Feroldi, Selena Maranjian, and Todd Campbell3 Medicare Benefits You Probably Didn't Know ExistedAre you taking full advantage of these little-known Medicare benefits?
Oct 28, 2016 by Brian FeroldiAcquisitions Cause FormFactor, Inc.'s Revenue and Profits to SoarThe semiconductor probe card manufacturer reports huge profit and earnings growth in the third quarter, but the company's near-term profit outlook prompted some traders to flee.
Oct 28, 2016 by Brian FeroldiHere's Why FormFactor, Inc. Is Tumbling TodayShares fall in response to the company's near-term profit guidance coming in a bit light of expectations.
Oct 27, 2016 by Brian FeroldiInfinera Muddles Through a Difficult Period and Predicts More Challenges AheadInfinera's third-quarter results came in slightly ahead of its guidance, but management projects more challenges ahead.
